Rosh K V Sethi1,2, Ashley L Miller1,2, Ryan A Bartholomew3, Ashton E Lehmann1,2, Regan W Bergmark1,4,5, Ahmad R Sedaghat1,2, Stacey T Gray1,2. 1. Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts. 2. Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts. 3. Harvard Medical School, Boston, Massachusetts. 4. Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Boston, Massachusetts, U.S.A. 5. Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts, U.S.A.
Abstract
OBJECTIVES/HYPOTHESIS: Opioid-related deaths in the United States have increased 200% since 2000, in part due to prescription diversion from patients who had a surgical procedure. The purpose of this study was to characterize provider prescription patterns and assess patient-reported opioid use after endoscopic sinus surgery (ESS). STUDY DESIGN: Retrospective chart review. METHODS: Patients who underwent ESS between May 2017 and May 2018 were included. Opioid prescription, operative details, and postoperative opioid use data were extracted. The Massachusetts Prescription Awareness Tool (MassPAT) was queried to determine if patients filled their prescription. RESULTS: One hundred fifty-five patients were included. Nearly all patients received an opioid prescription (94.8%). An average of 15.6 tablets was prescribed per patient. Among 116 patients with MassPAT data, 91.4% filled their prescription. Among 67 patients who reported the number of tablets they had used at the time of first follow-up appointment, 73.1% reported taking no opioids. Mean number of tablets prescribed was significantly greater among patients who underwent primary versus revision surgery (16.5 vs. 13.5, P = .0111) and those who had splints placed (21.5 vs. 15.1, P = .0037). Predictors of opioid use included concurrent turbinate reduction (58.3% vs. 14.3%, P < .0001) and concurrent septoplasty (45.5% vs. 21.6%, P = .039). CONCLUSIONS: Nearly all patients who underwent ESS were prescribed an opioid, and nearly all patients filled their prescription. However, the vast majority of patients did not require any opioid medication for postoperative pain control. As the opioid epidemic continues to persist, these findings have immediate relevance to current prescribing patterns and pain management practices. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:1046-1052, 2019.
OBJECTIVES/HYPOTHESIS: Opioid-related deaths in the United States have increased 200% since 2000, in part due to prescription diversion from patients who had a surgical procedure. The purpose of this study was to characterize provider prescription patterns and assess patient-reported opioid use after endoscopic sinus surgery (ESS). STUDY DESIGN: Retrospective chart review. METHODS:Patients who underwent ESS between May 2017 and May 2018 were included. Opioid prescription, operative details, and postoperative opioid use data were extracted. The Massachusetts Prescription Awareness Tool (MassPAT) was queried to determine if patients filled their prescription. RESULTS: One hundred fifty-five patients were included. Nearly all patients received an opioid prescription (94.8%). An average of 15.6 tablets was prescribed per patient. Among 116 patients with MassPAT data, 91.4% filled their prescription. Among 67 patients who reported the number of tablets they had used at the time of first follow-up appointment, 73.1% reported taking no opioids. Mean number of tablets prescribed was significantly greater among patients who underwent primary versus revision surgery (16.5 vs. 13.5, P = .0111) and those who had splints placed (21.5 vs. 15.1, P = .0037). Predictors of opioid use included concurrent turbinate reduction (58.3% vs. 14.3%, P < .0001) and concurrent septoplasty (45.5% vs. 21.6%, P = .039). CONCLUSIONS: Nearly all patients who underwent ESS were prescribed an opioid, and nearly all patients filled their prescription. However, the vast majority of patients did not require any opioid medication for postoperative pain control. As the opioid epidemic continues to persist, these findings have immediate relevance to current prescribing patterns and pain management practices. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:1046-1052, 2019.
Authors: Isabelle V Carter; Michael J Callegari; Tarun K Jella; Amr Mahran; Thomas B Cwalina; Wade Muncey; Aram Loeb; Nannan Thirumavalavan Journal: Int J Impot Res Date: 2022-01-07 Impact factor: 2.896
Authors: Austin T K Hoke; Madison Malfitano; Adam M Zanation; Charles S Ebert; Brent A Senior; Adam J Kimple; Brian D Thorp Journal: J Neurol Surg B Skull Base Date: 2021-12-17
Authors: Amr F Hamour; Frederick Laliberte; Jordan Levy; Jason Xu; Edward Park; Vincent Lin; John de Almeida; Julie Strychowsky; Antoine Eskander; Eric Monteiro Journal: World J Otorhinolaryngol Head Neck Surg Date: 2022-03-09
Authors: Bradley R Hall; Katherine L Billue; Heidi Hon; Stacey E Sanders; Stephan Barrientos; Laura E Flores; Thomas Nicholas; Valerie Shostrom; Bria Meyer; Perry J Johnson Journal: Plast Reconstr Surg Glob Open Date: 2020-12-21